Esophagus cancer, Gastric cancer, Colorectal cancer
Conditions
Interventions
Sponsors
Ayuse Takao
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Age: Adult patients aged 20 to 85 years of age at the time of consent acquisition 2 Gender: Any question 3 hospitalization / outpatient: hospitalization only 4 Patients who received written consent by their own free will after thorough understanding before participating in this study
Exclusion criteria
Exclusion criteria: 1 Continuous administration of oxygen by nasal cannula (home oxygen therapy) 2 Patients who cannot breathe in the nose Patients who need to stop antithrombotic drugs before 3 endoscopes 3 Patients who cannot reduce or stop the antithrombotic drug on the day before the endoscope 4 Patients with a history of pneumothorax 5 Other patients judged by the research director as inappropriate for study 6 Patients who are positive for the new coronavirus (SARS-CoV-2) PCR test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Occurrence of marked hypercarbonemia showing maximum value of percutaneous carbon dioxide concentration over 60 mmHg (equivalent to PaCO2> 55 mmHg) during intravenous anesthesia 2) Area under curve (AUC) of percutaneous carbon dioxide concentration per unit time at intravenous anesthesia 3) Duration of moderate hypercarbonemia showing maximum value of 50mmHg or more (equivalent to PaCO2> 45mmHg) during percutaneous anesthesia with intravenous anesthesia 4) Occurrence of hypoxemia showing 90% or less of the value of percutaneous oxygen saturation during intravenous anesthesia | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Anesthesia depth assessment (Ramsay scale) 2) Anesthesia dose | — |
Contacts
Public ContactTakao Ayuse
Nagasaki University Hospital
Outcome results
None listed